Work

Povetacicept for IgAN: Design of a Phase 3 Randomized, Placebo-Controlled Study

Year: 2025

Type: article

Study design: Study Protocol

Source: Journal of the American Society of Nephrology

DOI: 10.1681/asn.20259w7as0p8

Authors: Jiahua Li, Fengjuan Xuan, Ogo I. Egbuna, Richard A. Lafayette, Jonathan Barratt

Institutions: Vertex Pharmaceuticals (United States), Stanford University, University of Leicester

Language: English

Topic: Renal Diseases and Glomerulopathies

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416066918

FWCI:

Cites:

Cited by:

Related to: 10